Stryker Corporation(SYK)Earnings, Financials & Key Ratios

SYK•NYSE

$295.25

$113.08B mkt cap·35.1× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryOrthopedics, spine, and sports medicine

AboutStryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.Show more

Revenue$25.12B+11.2%
EBITDA$6.08B-0.5%
Net Income$3.25B+8.5%
EPS (Diluted)8.40+8.2%
Gross Margin63.96%+3.4%
EBITDA Margin24.22%-10.5%
Operating Margin19.47%-13.1%
Net Margin12.92%-2.4%
ROE15.08%-1.2%
ROIC11.39%-9.6%
Debt/Equity0.66-3.1%
Interest Coverage8.44-14.1%

Analysis→Technical→

SYK Key Insights

Stryker Corporation (SYK) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Dividend Aristocrat: 34 years of consecutive increases
✓Strong 5Y profit CAGR of 15.2%
✓FCF machine: 17.1% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 11.8%
✓Good 3Y average ROE of 16.1%

✗Weaknesses

✗Weak momentum: RS Rating 18 (bottom 18%)

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SYK Price & Volume

Stryker Corporation (SYK) stock price & volume — 10-year historical chart

Loading chart...

SYK Growth Metrics

Stryker Corporation (SYK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years9.71%

5 Years11.84%

3 Years10.83%

TTM11.16%

Profit CAGR

10 Years8.47%

5 Years15.21%

3 Years11.24%

TTM8.45%

EPS CAGR

10 Years8.31%

5 Years14.87%

3 Years10.83%

TTM8.25%

Return on Capital

10 Years13.83%

5 Years13.33%

3 Years13.89%

Last Year12.97%

SYK Recent Earnings

Stryker Corporation (SYK) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)

Q2 2026Latest

Apr 30, 2026

EPS

$2.60

Est $2.98

-12.8%

Revenue

$6.0B

Est $6.3B

-5.0%

Q1 2026

Jan 29, 2026

EPS

$4.47

Est $4.40

+1.6%

Revenue

$7.2B

Est $7.1B

+0.7%

Q4 2025

Oct 30, 2025

EPS

$3.19

Est $3.13

+1.9%

Revenue

$6.1B

Est $6.0B

+0.2%

Q3 2025

Jul 31, 2025

EPS

$3.13

Est $3.07

+2.0%

Revenue

$6.0B

Est $5.9B

+1.4%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 30, 2026	$2.60vs $2.98-12.8%	$6.0Bvs $6.3B-5.0%
Q1 2026	Jan 29, 2026	$4.47vs $4.40+1.6%	$7.2Bvs $7.1B+0.7%
Q4 2025	Oct 30, 2025	$3.19vs $3.13+1.9%	$6.1Bvs $6.0B+0.2%
Q3 2025	Jul 31, 2025	$3.13vs $3.07+2.0%	$6.0Bvs $5.9B+1.4%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
ZBHZimmer Biomet Holdings, Inc.Direct Competitor	16.25B	83.01	23.38	7.2%	9.05%	5.77%	9.06%	0.59
BSXBoston Scientific CorporationDirect Competitor	83.2B	55.98	28.86	19.87%	14.4%	12.4%	4.4%	0.51
EWEdwards Lifesciences CorporationDirect Competitor	47.8B	82.91	45.31	11.55%	17.64%	10.35%	2.79%	0.07
BDXBecton, Dickinson and CompanyDirect Competitor	52.23B	144.17	24.73	8.23%	8.01%	6.93%	5.11%	0.76
MDTMedtronic plcDirect Competitor	99.73B	77.79	21.55	3.62%	13%	9.45%	5.2%	0.59
SNNSmith & Nephew plcDirect Competitor	13.29B	31.31	21.74	6.34%	6.88%	15.06%	6.43%	0.63
HOLXHologic, Inc.Product Competitor	16.97B	76.01	30.53	1.74%	13.18%	10.37%	5.42%	0.52
GMEDGlobus Medical, Inc.Product Competitor	12.18B	90.03	22.97	16.65%	18.3%	12.4%	4.84%	0.03

Compare SYK vs Peers

Stryker Corporation (SYK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ZBH

Most directly comparable listed peer for SYK.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare SYK against a more recognizable public peer.

Peer Set

Compare Top 5

vs ZBH, BSX, EW, BDX

SYK Income Statement

Stryker Corporation (SYK) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	12.44B	13.6B	14.88B	14.35B	17.11B	18.45B	20.5B	22.59B	25.12B
Revenue Growth %	9.88%	9.3%	9.43%	-3.58%	19.21%	7.84%	11.11%	10.23%	11.16%
Cost of Goods Sold	4.54B	5B	5.5B	5.6B	6.4B	7.41B	8B	8.62B	9.05B
COGS % of Revenue	36.49%	36.77%	36.97%	39.01%	37.4%	40.16%	39.05%	38.13%	36.04%
Gross Profit	7.9B▲ 0%	8.6B▲ 8.8%	9.38B▲ 9.1%	8.75B▼ 6.7%	10.71B▲ 22.3%	11.04B▲ 3.1%	12.49B▲ 13.2%	13.98B▲ 11.9%	16.07B▲ 14.9%
Gross Margin %	63.51%	63.23%	63.03%	60.99%	62.6%	59.84%	60.95%	61.87%	63.96%
Gross Profit Growth %	9.07%	8.82%	9.09%	-6.7%	22.35%	3.09%	13.17%	11.89%	14.91%
Operating Expenses	5.14B	5.5B	5.99B	5.72B	6.95B	7.31B	8.21B	8.92B	11.18B
OpEx % of Revenue	41.27%	40.41%	40.27%	39.89%	40.6%	39.6%	40.07%	39.47%	44.5%
Selling, General & Admin	4.35B	4.63B	5.02B	4.82B	5.81B	6.08B	6.92B	7.5B	8.65B
SG&A % of Revenue	34.95%	34.07%	33.75%	33.59%	33.98%	32.93%	33.76%	33.22%	34.44%
Research & Development	787M	862M	971M	905M	1.13B	1.23B	1.29B	1.41B	1.58B
R&D % of Revenue	6.32%	6.34%	6.52%	6.31%	6.62%	6.67%	6.31%	6.26%	6.3%
Other Operating Expenses	0	0	0	0	0	0	0	0	902M
Operating Income	2.77B▲ 0%	3.1B▲ 12.2%	3.39B▲ 9.1%	3.03B▼ 10.6%	3.76B▲ 24.3%	3.73B▼ 0.8%	4.28B▲ 14.6%	5.06B▲ 18.2%	4.89B▼ 3.4%
Operating Margin %	22.24%	22.82%	22.76%	21.1%	22%	20.24%	20.89%	22.4%	19.47%
Operating Income Growth %	7.37%	12.18%	9.15%	-10.63%	24.27%	-0.77%	14.65%	18.22%	-3.4%
EBITDA	3.41B	3.83B	4.17B	3.84B	4.75B	4.73B	5.31B	6.11B	6.08B
EBITDA Margin %	27.39%	28.14%	27.99%	26.76%	27.78%	25.65%	25.9%	27.05%	24.22%
EBITDA Growth %	9.16%	12.26%	8.86%	-7.83%	23.78%	-0.44%	12.19%	15.11%	-0.47%
D&A (Non-Cash Add-back)	642M	723M	778M	812M	990M	998M	1.03B	1.05B	1.19B
EBIT	2.31B	2.62B	2.85B	2.27B	2.62B	3.02B	4.03B	3.89B	5.12B
Net Interest Income	-187M	-145M	-132M	-213M	-269M	-243M	-281M	-257M	-486M
Interest Income	60M	119M	155M	102M	68M	94M	75M	139M	121M
Interest Expense	247M	264M	287M	315M	337M	337M	356M	396M	607M
Other Income/Expense	-704M	-748M	-826M	-1.07B	-1.48B	-1.05B	-608M	-1.57B	-375M
Pretax Income	2.06B▲ 0%	2.36B▲ 14.2%	2.56B▲ 8.7%	1.95B▼ 23.7%	2.28B▲ 16.7%	2.68B▲ 17.6%	3.67B▲ 36.9%	3.49B▼ 4.9%	4.51B▲ 29.3%
Pretax Margin %	16.58%	17.32%	17.21%	13.62%	13.33%	14.54%	17.92%	15.45%	17.97%
Income Tax	1.04B	-1.2B	479M	355M	287M	325M	508M	499M	1.27B
Effective Tax Rate %	50.56%	-50.81%	18.7%	18.17%	12.58%	12.11%	13.83%	14.29%	28.09%
Net Income	1.02B▲ 0%	3.55B▲ 248.3%	2.08B▼ 41.4%	1.6B▼ 23.2%	1.99B▲ 24.7%	2.36B▲ 18.3%	3.17B▲ 34.2%	2.99B▼ 5.4%	3.25B▲ 8.5%
Net Margin %	8.2%	26.12%	13.99%	11.14%	11.66%	12.78%	15.44%	13.25%	12.92%
Net Income Growth %	-38.07%	248.33%	-41.37%	-23.24%	24.7%	18.25%	34.22%	-5.43%	8.45%
Net Income (Continuing)	1.02B	3.55B	2.08B	1.6B	1.99B	2.36B	3.17B	2.99B	3.25B
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	14M	0	0	0	0	0	0	0	0
EPS (Diluted)	2.68▲ 0%	9.34▲ 248.5%	5.48▼ 41.3%	4.20▼ 23.4%	5.22▲ 24.3%	6.17▲ 18.2%	8.25▲ 33.7%	7.76▼ 5.9%	8.40▲ 8.2%
EPS Growth %	-38.39%	248.51%	-41.33%	-23.36%	24.29%	18.2%	33.71%	-5.94%	8.25%
EPS (Basic)	2.73	9.50	5.57	4.26	5.29	6.23	8.34	7.86	8.49
Diluted Shares Outstanding	380.1M	380.3M	379.9M	380.3M	382.3M	382.2M	383.7M	385.6M	382.2M
Basic Shares Outstanding	374M	374.1M	374M	375.5M	377M	378.2M	379.6M	381M	382.2M
Dividend Payout Ratio	62.35%	19.79%	37.35%	53.97%	47.64%	44.57%	35.99%	40.73%	39.56%

SYK Balance Sheet

Stryker Corporation (SYK) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	7.99B	9.73B	11.36B	9.71B	10.02B	10.28B	12.52B	14.85B	14.76B
Cash & Short-Term Investments	2.79B	3.7B	4.42B	3.02B	3.02B	1.93B	3.05B	4.49B	4.1B
Cash Only	2.54B	3.62B	4.34B	2.94B	2.94B	1.84B	2.97B	3.65B	4.01B
Short-Term Investments	251M	83M	88M	81M	75M	84M	82M	841M	89M
Accounts Receivable	2.2B	2.33B	2.89B	2.7B	3.02B	3.56B	3.77B	3.99B	4.04B
Days Sales Outstanding	64.47	62.58	70.94	68.7	64.47	70.53	67.04	64.41	58.7
Inventory	2.46B	2.96B	3.28B	3.49B	3.31B	4B	4.84B	4.77B	5.31B
Days Inventory Outstanding	198.13	215.67	217.73	227.82	189.03	196.81	220.85	202.26	214.14
Other Current Assets	537M	747M	760M	488M	662M	787M	857M	1.59B	1.31B
Total Non-Current Assets	14.19B	17.5B	18.81B	24.62B	24.61B	26.61B	27.39B	28.12B	33.09B
Property, Plant & Equipment	1.98B	2.29B	2.95B	3.17B	3.25B	3.44B	3.71B	3.96B	3.88B
Fixed Asset Turnover	6.30x	5.94x	5.04x	4.52x	5.26x	5.36x	5.53x	5.70x	6.48x
Goodwill	7.17B	8.56B	9.07B	12.78B	12.92B	14.88B	15.24B	15.86B	24.97B
Intangible Assets	3.48B	4.16B	4.23B	5.55B	4.84B	4.88B	4.59B	4.39B	0
Long-Term Investments	0	0	0	4M	66M	90M	2M	39M	0
Other Non-Current Assets	1.3B	801M	985M	1.58B	1.78B	1.9B	2.18B	2.13B	3.14B
Total Assets	22.18B▲ 0%	27.23B▲ 22.7%	30.17B▲ 10.8%	34.33B▲ 13.8%	34.63B▲ 0.9%	36.88B▲ 6.5%	39.91B▲ 8.2%	42.97B▲ 7.7%	47.84B▲ 11.3%
Asset Turnover	0.56x	0.50x	0.49x	0.42x	0.49x	0.50x	0.51x	0.53x	0.52x
Asset Growth %	8.55%	22.75%	10.79%	13.8%	0.88%	6.51%	8.21%	7.66%	11.34%
Total Current Liabilities	3.29B	4.81B	4.4B	5.04B	4.55B	6.3B	7.92B	7.62B	7.79B
Accounts Payable	487M	646M	675M	810M	1.13B	1.41B	1.52B	1.68B	0
Days Payables Outstanding	39.14	47.15	44.78	52.81	64.4	69.61	69.18	71.14	-
Short-Term Debt	632M	1.37B	945M	870M	119M	1.31B	2.24B	1.55B	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0
Other Current Liabilities	1.39B	1.71B	1.65B	2.23B	2.02B	2.14B	2.3B	2.44B	7.79B
Current Ratio	2.43x	2.02x	2.58x	1.93x	2.20x	1.63x	1.58x	1.95x	1.89x
Quick Ratio	1.68x	1.41x	1.84x	1.23x	1.47x	1.00x	0.97x	1.32x	1.21x
Cash Conversion Cycle	223.46	231.11	243.89	243.7	189.11	197.73	218.71	195.53	-
Total Non-Current Liabilities	8.73B	10.69B	12.96B	16.2B	15.21B	13.96B	13.4B	14.72B	17.63B
Long-Term Debt	6.59B	8.49B	10.23B	13.23B	12.47B	11.86B	10.9B	12.19B	14.86B
Capital Lease Obligations	0	0	301M	325M	310M	357M	356M	379M	0
Deferred Tax Liabilities	47M	54M	108M	117M	68M	67M	63M	82M	0
Other Non-Current Liabilities	2.1B	2.15B	2.32B	2.53B	2.35B	1.68B	2.08B	2.07B	2.77B
Total Liabilities	12.22B	15.5B	17.36B	21.25B	19.75B	20.27B	21.32B	22.34B	25.42B
Total Debt	7.22B	9.86B	11.48B	14.43B	12.9B	13.53B	13.49B	14.12B	14.86B
Net Debt	4.68B	6.24B	7.14B	11.48B	9.96B	11.68B	10.52B	10.47B	10.85B
Debt / Equity	0.72x	0.84x	0.90x	1.10x	0.87x	0.81x	0.73x	0.68x	0.66x
Debt / EBITDA	2.12x	2.58x	2.75x	3.76x	2.71x	2.86x	2.54x	2.31x	2.44x
Net Debt / EBITDA	1.37x	1.63x	1.71x	2.99x	2.09x	2.47x	1.98x	1.71x	1.78x
Interest Coverage	9.35x	9.92x	9.93x	7.20x	7.77x	8.96x	11.32x	9.82x	8.44x
Total Equity	9.98B▲ 0%	11.73B▲ 17.5%	12.81B▲ 9.2%	13.08B▲ 2.2%	14.88B▲ 13.7%	16.62B▲ 11.7%	18.59B▲ 11.9%	20.63B▲ 11.0%	22.42B▲ 8.7%
Equity Growth %	4.5%	17.54%	9.18%	2.16%	13.7%	11.69%	11.9%	10.98%	8.66%
Book Value per Share	26.26	30.84	33.71	34.40	38.91	43.47	48.46	53.51	58.66
Total Shareholders' Equity	9.97B	11.73B	12.81B	13.08B	14.88B	16.62B	18.59B	20.63B	22.42B
Common Stock	37M	37M	37M	38M	38M	38M	38M	38M	0
Retained Earnings	8.99B	10.77B	11.75B	12.46B	13.48B	14.77B	16.77B	18.53B	0
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	-553M	-631M	-606M	-1.16B	-531M	-221M	-416M	-293M	0
Minority Interest	14M	0	0	0	0	0	0	0	0

SYK Cash Flow Statement

Stryker Corporation (SYK) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	1.56B	2.61B	2.19B	3.28B	3.26B	2.62B	3.71B	4.24B	5.04B
Operating CF Margin %	12.53%	19.19%	14.72%	22.83%	19.07%	14.22%	18.1%	18.77%	20.08%
Operating CF Growth %	-18.59%	67.42%	-16.05%	49.57%	-0.43%	-19.58%	41.43%	14.31%	18.91%
Net Income	1.02B	3.55B	2.08B	1.6B	1.99B	2.36B	3.17B	2.99B	3.25B
Depreciation & Amortization	642M	723M	778M	812M	990M	998M	1.03B	1.05B	1.19B
Stock-Based Compensation	113M	119M	127M	142M	171M	168M	205M	229M	243M
Deferred Taxes	36M	-1.58B	126M	48M	-237M	58M	-206M	-370M	392M
Other Non-Cash Items	-149M	1.46B	-253M	-190M	66M	-226M	19M	1.02B	343M
Working Capital Changes	-103M	-1.67B	-670M	866M	279M	-732M	-500M	-683M	-373M
Change in Receivables	-162M	-60M	-563M	354M	-377M	-579M	-175M	-321M	127M
Change in Inventory	-320M	-385M	-400M	27M	-189M	-762M	-797M	-206M	-297M
Change in Payables	21M	116M	63M	100M	329M	290M	77M	192M	94M
Cash from Investing	-1.61B	-2.86B	-1.46B	-4.7B	-859M	-2.92B	-962M	-3B	-4.87B
Capital Expenditures	-598M	-572M	-649M	-487M	-525M	-588M	-575M	-755M	-761M
CapEx % of Revenue	4.81%	4.21%	4.36%	3.39%	3.07%	3.19%	2.81%	3.34%	3.03%
Acquisitions	-831M	-2.45B	-802M	-4.22B	-339M	-2.56B	-390M	-1.63B	-4.79B
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-1M	-2M	1M	1M	-1M	39M	1M	43M	-60M
Cash from Financing	-794M	1.33B	3M	-11M	-2.37B	-749M	-1.59B	-525M	113M
Debt Issued (Net)	299M	2.46B	1.29B	989M	-1.15B	472M	-277M	940M	1.58B
Equity Issued (Net)	-230M	-300M	-307M	-110M	-114M	-122M	-155M	-195M	0
Dividends Paid	-636M	-703M	-778M	-863M	-950M	-1.05B	-1.14B	-1.22B	-1.28B
Share Repurchases	-230M	-300M	-307M	-110M	-114M	-122M	-155M	-195M	0
Other Financing	-227M	-124M	-205M	-27M	-148M	-48M	-23M	-51M	-182M
Net Change in Cash	-774M▲ 0%	1.07B▲ 238.8%	721M▼ 32.9%	-1.39B▼ 293.3%	1M▲ 100.1%	-1.1B▼ 110100.0%	1.13B▲ 202.5%	681M▼ 39.6%	359M▼ 47.3%
Free Cash Flow	961M▲ 0%	2.04B▲ 112.1%	1.54B▼ 24.3%	2.79B▲ 80.9%	2.74B▼ 1.9%	2.04B▼ 25.6%	3.14B▲ 54.0%	3.49B▲ 11.2%	4.28B▲ 22.8%
FCF Margin %	7.72%	14.98%	10.36%	19.44%	16%	11.04%	15.3%	15.43%	17.05%
FCF Growth %	-32.56%	112.07%	-24.34%	80.93%	-1.86%	-25.64%	54.03%	11.19%	22.83%
FCF per Share	2.53	5.36	4.06	7.34	7.16	5.33	8.17	9.04	11.21
FCF Conversion (FCF/Net Income)	1.53x	0.73x	1.05x	2.05x	1.64x	1.11x	1.17x	1.42x	1.55x
Interest Paid	231M	248M	286M	304M	325M	324M	356M	396M	0
Taxes Paid	312M	539M	457M	323M	622M	505M	693M	989M	0

SYK Key Ratios

Stryker Corporation (SYK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	18.24%	10.45%	32.73%	16.98%	12.35%	14.26%	14.97%	17.98%	15.26%	15.08%
Return on Invested Capital (ROIC)	17.35%	14.93%	14.27%	13.4%	10.2%	11.43%	10.54%	11.18%	12.61%	11.39%
Gross Margin	63.98%	63.51%	63.23%	63.03%	60.99%	62.6%	59.84%	60.95%	61.87%	63.96%
Net Margin	14.54%	8.2%	26.12%	13.99%	11.14%	11.66%	12.78%	15.44%	13.25%	12.92%
Debt / Equity	0.72x	0.72x	0.84x	0.90x	1.10x	0.87x	0.81x	0.73x	0.68x	0.66x
Interest Coverage	9.43x	9.35x	9.92x	9.93x	7.20x	7.77x	8.96x	11.32x	9.82x	8.44x
FCF Conversion	1.16x	1.53x	0.73x	1.05x	2.05x	1.64x	1.11x	1.17x	1.42x	1.55x
Revenue Growth	13.86%	9.88%	9.3%	9.43%	-3.58%	19.21%	7.84%	11.11%	10.23%	11.16%

SYK SEC Filings & Documents

Stryker Corporation (SYK) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Mar 23, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 12, 2025·SEC

10-Q Quarterly Reports

FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 1, 2025·SEC

FY 2025

May 2, 2025·SEC

SYK Frequently Asked Questions

Stryker Corporation (SYK) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Stryker Corporation (SYK) reported $25.12B in revenue for fiscal year 2025. This represents a 2660% increase from $910.1M in 1996.

Stryker Corporation (SYK) grew revenue by 11.2% over the past year. This is steady growth.

Yes, Stryker Corporation (SYK) is profitable, generating $3.25B in net income for fiscal year 2025 (12.9% net margin).

Dividend & Returns

Yes, Stryker Corporation (SYK) pays a dividend with a yield of 1.14%. This makes it attractive for income-focused investors.

Stryker Corporation (SYK) has a return on equity (ROE) of 15.1%. This is reasonable for most industries.

Stryker Corporation (SYK) generated $4.28B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SYK

Stryker Corporation (SYK) financial analysis — history, returns, DCA and operating performance tools

Full SYK Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Stryker Corporation(SYK)Earnings, Financials & Key Ratios

SYK Key Insights

✓Strengths

✗Weaknesses

SYK Price & Volume

SYK Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

SYK Recent Earnings

SYK Peer Comparison

Compare SYK vs Peers

vs ZBH

vs JNJ

Compare Top 5

SYK Income Statement

SYK Balance Sheet

SYK Cash Flow Statement

SYK Key Ratios

SYK SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

SYK Frequently Asked Questions

Explore More SYK

Full SYK Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation